Drug Type in vivo CAR-T therapy |
Synonyms SG 239, SG-239, SG239 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD8 modulators(Cluster of differentiation 8 modulators), Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Myeloma | Preclinical | United States | - |





